Most Kids With COVID-Linked MIS-C Recover by 6 MonthsJanuary 14, 2025COVID-19 UpdatesInfectious DiseasesCardiologyRare Diseases
Alpha-Gal Syndrome: 5 Things to KnowDecember 19, 2024ImmunologyDermatologyGastroenterologyRare Diseases
Health Impacts of Micro- and NanoplasticsDecember 17, 2024EndocrinologyPulmonologyNeurologyRare Diseases
Special Considerations Needed in Applying Lupus Nephritis Guideline to ChildrenDecember 12, 2024Rare DiseasesNephrology
Project’s Improvement in JIA Outcome Disparities Sets Stage for Further InterventionsDecember 9, 2024Rare DiseasesMusculoskeletal Disorders
Could Biomarkers Help to Detect Lung Disease Earlier in Systemic JIA?December 9, 2024PulmonologyRare DiseasesMusculoskeletal Disorders
JIA Treatment Has Increasingly Involved New DMARDs Since 2001November 4, 2024Musculoskeletal DisordersRare Diseases
Rheumatologic Disease–Associated Hyperinflammatory Condition Successfully Treated with EmapalumabSeptember 27, 2024Rare Diseases
GI Involvement Often Present at Time of Pediatric Lupus Diagnosis or Soon AfterSeptember 10, 2024Rare Diseases
Neurofibromatosis: What Affects Quality of Life Most?September 4, 2024Rare DiseasesDermatologyMental HealthMixed Topics
Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Rare DiseasesMusculoskeletal DisordersDermatologyGastroenterology
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic ArthritisJune 26, 2024Rare DiseasesMusculoskeletal Disorders
